Stomach Neoplasms: all 2,914 studies
Page 16 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
- Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric CancerStatus unknownNCT05052931Phase 2
- Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionCompletedNCT05052801Phase 3
- da Vinci SP Robotic GastrectomyCompletedNCT05051670Not applicable
- "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES)Status unknownNCT05051423
- Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced CancersWithdrawnNCT05043987Phase 1
- Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
- Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical NavigationStatus unknownNCT05039333
- Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
- Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric CancerStatus unknownNCT05035446Phase 3
- Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study DescriptionActive, not recruitingNCT05029869
- Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 TherapyStatus unknownNCT05029453Phase 4
- Detection of Plasma Circulating Tumor DNA in Gastric CancerStatus unknownNCT05027347
- Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based ChemotherapyCompletedNCT05025826Not applicable
- Chemotherapy Combined With Apatinib and PD-1 AntibodyCompletedNCT05025033Phase 2
- Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsStatus unknownNCT05019794Phase 2
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTerminatedNCT05013554Phase 1
- Prospective Observational Study Comparing the Use of Circular (Orvil) and Linear Stapler for Intracorporeal EsophagojejunostomyStatus unknownNCT05007912
- Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node MetastasisStatus unknownNCT05002686Phase 2/3
- A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)Active, not recruitingNCT05002127Phase 2/3
- Multi-center and Multi-modal Deep Learning Study of Gastric CancerStatus unknownNCT05001321
- COMPARATIVE EFFECTS OF PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY ON OUTCOMES OF OPERABLE GASTRIC CANCER: EXPERIENCE FROM A CANCER CARE CENTERCompletedNCT04989764
- Nasal Endoscopic Screening and Risk Assessment for Early Gastric CancerStatus unknownNCT04989153
- Development and Testing of a Social Cognitive Theory-based Dietary Behavioral Intervention in Gastric Cancer SurvivorsCompletedNCT04985084Not applicable
- Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric CancerStatus unknownNCT04982939Phase 2
- "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"Status unknownNCT04980950Not applicable
- EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjectionTerminatedNCT04977401Not applicable
- The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective StudyCompletedNCT04973631
- Cohort Study Comparing Surgeon Stress, Utilization of Surgical Instruments, Surgical Outcomes According to Surgical Approach for GastrectomyStatus unknownNCT04972149
- Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT)CompletedNCT04963088Phase 1/2
- The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine LearningStatus unknownNCT04957407
- Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer PatientsCompletedNCT04953585
- Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric AdenocarcinomaStatus unknownNCT04948125Phase 2
- Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric CancerStatus unknownNCT04947995
- Perioperative Chemotherapy in Gastric CancerTerminatedNCT04937738Phase 2
- A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)TerminatedNCT04933227Phase 2
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid CancerActive, not recruitingNCT04931654Phase 1/2
- Analysis of Influencing Factors of Preoperative Frailty in Elderly Patients With Gastric Cancer Based on the Health Ecology TheoryCompletedNCT04929587
- Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma PatientsCompletedNCT04923932Phase 2
- Real-world Data (RWD) of Ramucirumab Plus PaclitaxelStatus unknownNCT04915807
- CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or ImmunotherapyStatus unknownNCT04913896
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT04913662Phase 1
- Submucosal Tumor Removal by Endoscopic Excision TherapySuspendedNCT04913077Not applicable
- Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric CancerActive, not recruitingNCT04908813Phase 2
- Postoperative Prognosis Management Service Based mHealth for Gastric Cancer PatientsStatus unknownNCT04907591Not applicable
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompletedNCT04902872Phase 1/2
- Enterotomy Closure and Minimally Invasive GastrectomyCompletedNCT04901585
- Vactosertib and Durvalumab in Gastric CancerStatus unknownNCT04893252Phase 2
- Study of ESG401 in Adults With Solid TumorsCompletedNCT04892342Phase 1/2
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- Impact of Biliopancreatic Limb Length on Diabetes Following Distal GastrectomyCompletedNCT04889859Not applicable
- Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)Status unknownNCT04888663Phase 1/2
- FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal MetastasisStatus unknownNCT04886193Not applicable
- Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRGActive, not recruitingNCT04878783
- Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric CancerCompletedNCT04871204Phase 2
- Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric CancerStatus unknownNCT04869618Not applicable
- Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationTerminatedNCT04868877Phase 1/2
- The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular TrappingWithdrawnNCT04868747Not applicable
- A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract TumorsCompletedNCT04861987Phase 1
- Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China ExtensionWithdrawnNCT04859582Phase 3
- Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric CancerStatus unknownNCT04850716
- Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO StudyStatus unknownNCT04843397
- Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric CancerCompletedNCT04835896Phase 1/2
- Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous LesionsStatus unknownNCT04835246Not applicable
- Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical InstitutionCompletedNCT04834661
- Aberrant DNA Methylation to Predict Metachronous Gastric NeoplasmsCompletedNCT04830618
- Study of DP303c Injection in Patients With Advanced or Metastatic Gastric CancerStatus unknownNCT04826107Phase 2
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)CompletedNCT04825834
- The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Prognosis of Gastric CancerStatus unknownNCT04819958
- TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.Active, not recruitingNCT04817826Phase 2
- Gastrointestinal Anastomosis Using MonoPlus® SutureWithdrawnNCT04811833
- iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04808791Phase 2
- Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y ReconstructionStatus unknownNCT04801459Not applicable
- NuGa (Nutrition for Gastric Cancer Patients)CompletedNCT04800991Not applicable
- A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal DisseminationStatus unknownNCT04797923Phase 2
- Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?CompletedNCT04797624
- Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric CancerStatus unknownNCT04792515Phase 2
- The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric CancerCompletedNCT04791293
- Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric CancerStatus unknownNCT04782791Phase 2
- Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric CancerStatus unknownNCT04781413Phase 1/2
- Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric CancerStatus unknownNCT04778345Not applicable
- Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal CancerStatus unknownNCT04777162Phase 2
- A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesCompletedNCT04772989Phase 1
- Docetaxel and Irinotecan in Gastric CancerCompletedNCT04770623Phase 2
- BLI for the Diagnosis of Precancerous ConditionsCompletedNCT04768218
- Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal CarcinomatosisActive, not recruitingNCT04762953Phase 2
- An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric CancerActive, not recruitingNCT04745988Phase 2
- Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer TrialStatus unknownNCT04744649Phase 2
- Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)CompletedNCT04739202Phase 2
- Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric CancerActive, not recruitingNCT04725994Phase 1/2
- Application of OE in Diagnosis of EGCStatus unknownNCT04720521Not applicable
- A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric CarcinomaTerminatedNCT04718402Phase 1
- Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Active, not recruitingNCT04704934Phase 3
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialActive, not recruitingNCT04704661Phase 1
- Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric CancerStatus unknownNCT04694404Phase 2
- The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric CancerCompletedNCT04694183Phase 2
- Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsNo longer availableNCT04681248
- Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerCompletedNCT04670445Not applicable
- A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1